iRhythm Technologies announced that it intends to offer, subject to market conditions and other factors, $450M aggregate principal amount of Convertible Senior Notes due 2029 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. iRhythm also intends to grant the initial purchasers of the notes an option to purchase, within a 13-day period from, and including, the date on which the notes are first issued, up to an additional $67.5M aggregate principal amount of notes.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IRTC:
- iRhythm partners with Epic for Zio access
- iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients
- iRhythm price target raised to $135 from $125 at Wells Fargo
- iRhythm price target raised to $133 from $121 at Canaccord
- iRhythm price target raised to $135 from $125 at Baird